Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 848

1.

On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines.

Ortega A, Rangel-López E, Hidalgo-Miranda A, Morales A, Ruiz-García E, Meneses-García A, Herrera-Gómez A, Aguilar-Ponce JL, González-Herrera IG, Guevara-Salazar P, Prospero-García O, Del Angel SA.

Toxicol In Vitro. 2015 Aug 6;29(7):1941-1951. doi: 10.1016/j.tiv.2015.08.003. [Epub ahead of print]

PMID:
26255146
2.

The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer.

Xian S, Parayath NN, Nehoff H, Giles NM, Greish K.

Anticancer Res. 2015 Sep;35(9):4707-12.

PMID:
26254360
3.

The use of cannabinoids as anticancer agents.

Velasco G, Hernández-Tiedra S, Dávila D, Lorente M.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 10. pii: S0278-5846(15)00119-0. doi: 10.1016/j.pnpbp.2015.05.010. [Epub ahead of print] Review.

4.

Evaluation of the anti-inflammatory and antioxidative potential of four fern species from China intended for use as food supplements.

Dion C, Haug C, Guan H, Ripoll C, Spiteller P, Coussaert A, Boulet E, Schmidt D, Wei J, Zhou Y, Lamottke K.

Nat Prod Commun. 2015 Apr;10(4):597-603.

PMID:
25973486
5.

Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity.

Esain V, Kwan W, Carroll KJ, Cortes M, Liu SY, Frechette GM, Sheward LM, Nissim S, Goessling W, North TE.

Stem Cells. 2015 Aug;33(8):2596-612. doi: 10.1002/stem.2044. Epub 2015 May 26.

PMID:
25931248
6.

Differential role of cannabinoids in the pathogenesis of skin cancer.

Glodde N, Jakobs M, Bald T, Tüting T, Gaffal E.

Life Sci. 2015 Oct 1;138:35-40. doi: 10.1016/j.lfs.2015.04.003. Epub 2015 Apr 25.

PMID:
25921771
7.

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.

McAllister SD, Soroceanu L, Desprez PY.

J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67. doi: 10.1007/s11481-015-9608-y. Epub 2015 Apr 28.

PMID:
25916739
8.

Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.

Nabissi M, Morelli MB, Amantini C, Liberati S, Santoni M, Ricci-Vitiani L, Pallini R, Santoni G.

Int J Cancer. 2015 Oct 15;137(8):1855-69. doi: 10.1002/ijc.29573. Epub 2015 May 8.

PMID:
25903924
9.

Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival.

Martínez-Martínez E, Gómez I, Martín P, Sánchez A, Román L, Tejerina E, Bonilla F, Merino AG, de Herreros AG, Provencio M, García JM.

Oncoscience. 2015 Feb 9;2(2):131-41. eCollection 2015.

10.

Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.

Lynch ME, Ware MA.

J Neuroimmune Pharmacol. 2015 Jun;10(2):293-301. doi: 10.1007/s11481-015-9600-6. Epub 2015 Mar 22.

PMID:
25796592
11.

Genotoxic properties of representatives of alkylindazoles and aminoalkyl-indoles which are consumed as synthetic cannabinoids.

Koller VJ, Ferk F, Al-Serori H, Mišík M, Nersesyan A, Auwärter V, Grummt T, Knasmüller S.

Food Chem Toxicol. 2015 Jun;80:130-6. doi: 10.1016/j.fct.2015.03.004. Epub 2015 Mar 16.

PMID:
25792264
12.

Cannabis in cancer care.

Abrams DI, Guzman M.

Clin Pharmacol Ther. 2015 Jun;97(6):575-86. doi: 10.1002/cpt.108. Epub 2015 Apr 17. Review.

PMID:
25777363
13.

Pharmacological options for the management of refractory cancer pain-what is the evidence?

Afsharimani B, Kindl K, Good P, Hardy J.

Support Care Cancer. 2015 May;23(5):1473-81. doi: 10.1007/s00520-015-2678-9. Epub 2015 Mar 7. Review.

PMID:
25749509
14.

Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8.

Sido JM, Yang X, Nagarkatti PS, Nagarkatti M.

J Leukoc Biol. 2015 Apr;97(4):677-88. doi: 10.1189/jlb.1A1014-479R. Epub 2015 Feb 20.

PMID:
25713087
15.

Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.

Armstrong JL, Hill DS, McKee CS, Hernandez-Tiedra S, Lorente M, Lopez-Valero I, Eleni Anagnostou M, Babatunde F, Corazzari M, Redfern CP, Velasco G, Lovat PE.

J Invest Dermatol. 2015 Jun;135(6):1629-37. doi: 10.1038/jid.2015.45. Epub 2015 Feb 10.

PMID:
25674907
16.

Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer.

Morales P, Blasco-Benito S, Andradas C, Gómez-Cañas M, Flores JM, Goya P, Fernández-Ruiz J, Sánchez C, Jagerovic N.

J Med Chem. 2015 Mar 12;58(5):2256-64. doi: 10.1021/acs.jmedchem.5b00078. Epub 2015 Feb 20.

PMID:
25671648
17.

Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.

Fowler CJ.

Clin Pharmacol Ther. 2015 Jun;97(6):587-96. doi: 10.1002/cpt.84. Epub 2015 May 2. Review.

PMID:
25669486
19.

New insights into antimetastatic and antiangiogenic effects of cannabinoids.

Ramer R, Hinz B.

Int Rev Cell Mol Biol. 2015;314:43-116. doi: 10.1016/bs.ircmb.2014.10.005. Epub 2014 Dec 18.

PMID:
25619715
20.

Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans.

Sailler S, Schmitz K, Jäger E, Ferreiros N, Wicker S, Zschiebsch K, Pickert G, Geisslinger G, Walter C, Tegeder I, Lötsch J.

Oncoscience. 2014 Apr 30;1(4):272-82. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk